Trader consensus on Polymarket reflects a 92.6% implied probability against a new coronavirus pandemic in 2026, driven by SARS-CoV-2's transition to endemic low-level circulation worldwide. CDC data as of mid-April 2026 shows COVID-19 reproduction number (Rt) declining or stable in 33 U.S. states, with wastewater levels at historic lows and global WHO testing positivity under 1% in recent weeks. Updated 2025-2026 vaccines targeting JN.1-lineage strains remain effective against severe disease despite new variants like BA.3.2 ("Cicada") and others with partial immune escape detected in March. No explosive transmission or excess mortality signals a WHO public health emergency of international concern. Realistic challenges include a novel, highly virulent variant evading population immunity, prompting rapid reassessment via ongoing CDC and WHO surveillance updates.